TY - JOUR T1 - Financing global health security: estimating the costs of pandemic preparedness in Global Fund eligible countries JF - BMJ Global Health JO - BMJ Global Health DO - 10.1136/bmjgh-2022-008960 VL - 8 IS - 1 SP - e008960 AU - Stephanie Eaneff AU - Matthew R Boyce AU - Ellie Graeden AU - David Lowrance AU - Mackenzie Moore AU - Rebecca Katz Y1 - 2023/01/01 UR - http://gh.bmj.com/content/8/1/e008960.abstract N2 - Summary boxThe costs, globally, to build country-level public health capacity to address gaps in global health security over the next 5 years have been previously estimated as US$96–$204 billion, with an estimated US$63–131 billion in investment required over the next 3 years.Research conducted prior to the COVID-19 pandemic indicated that over one-third of Global Fund’s budgets in 10 case study countries aligned with health security priorities articulated by the Joint External Evaluation, particularly in the areas of laboratory systems, antimicrobial resistance and workforce development.We estimate that over 85% of investments needed to build country-level capacities in health security, globally, over the next 3 years are in countries eligible for Global Fund support.Areas of investment opportunity aligned with the Global Fund’s core mandate include financing for surveillance and laboratory systems, combating antimicrobial resistance and developing and supporting robust healthcare and public health workforces.In aggregate, global-level data highlight areas of opportunity for the Global Fund to expand and further develop its support of global health security in areas aligned with its mandate and programmatic scope.Such investment opportunities have implications for existing budgeting and allocation processes and for implementation models, partners, programming and governance structures should these areas of potential expansion be prioritised.This work emphasises a role for targeted, action-based cost estimation to identify gaps and to inform strategic investment decisions in global health.The COVID-19 pandemic demonstrated that the world was not well prepared to respond to an infectious disease threat of this magnitude. Countries across all socioeconomic and development categories have struggled to implement effective national responses. Substantial amounts of additional investment are required to support the development of country capacities to prevent, detect and respond to both existing and emerging infectious disease threats. Prior research efforts have estimated that between US$96 and $204 billion is required, globally, to advance country-level health … ER -